GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (NYSE:MCK) » Definitions » Beneish M-Score

McKesson (McKesson) Beneish M-Score

: -2.32 (As of Today)
View and export this data going back to 1987. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.32 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for McKesson's Beneish M-Score or its related term are showing as below:

MCK' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: -2.57   Max: -2.2
Current: -2.32

During the past 13 years, the highest Beneish M-Score of McKesson was -2.20. The lowest was -2.90. And the median was -2.57.


McKesson Beneish M-Score Historical Data

The historical data trend for McKesson's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.64 -2.59 -2.57 -2.77 -2.40

McKesson Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 -2.40 -2.34 -2.34 -2.32

Competitive Comparison

For the Medical Distribution subindustry, McKesson's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Beneish M-Score Distribution

For the Medical Distribution industry and Healthcare sector, McKesson's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where McKesson's Beneish M-Score falls into.



McKesson Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of McKesson for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0203+0.528 * 1.1277+0.404 * 0.9923+0.892 * 1.1008+0.115 * 0.9823
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9181+4.679 * -0.004691-0.327 * 1.0085
=-2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $23,066 Mil.
Revenue was 80898 + 77215 + 74483 + 68910 = $301,506 Mil.
Gross Profit was 3152 + 3069 + 3022 + 3066 = $12,309 Mil.
Total Current Assets was $47,640 Mil.
Total Assets was $66,512 Mil.
Property, Plant and Equipment(Net PPE) was $3,880 Mil.
Depreciation, Depletion and Amortization(DDA) was $636 Mil.
Selling, General, & Admin. Expense(SGA) was $8,432 Mil.
Total Current Liabilities was $51,661 Mil.
Long-Term Debt & Capital Lease Obligation was $7,046 Mil.
Net Income was 589 + 664 + 958 + 787 = $2,998 Mil.
Non Operating Income was 30 + 0 + -14 + -198 = $-182 Mil.
Cash Flow from Operations was 254 + 965 + -1052 + 3325 = $3,492 Mil.
Total Receivables was $20,537 Mil.
Revenue was 70490 + 70157 + 67154 + 66102 = $273,903 Mil.
Gross Profit was 3174 + 3095 + 3023 + 3318 = $12,610 Mil.
Total Current Assets was $44,657 Mil.
Total Assets was $62,690 Mil.
Property, Plant and Equipment(Net PPE) was $3,793 Mil.
Depreciation, Depletion and Amortization(DDA) was $609 Mil.
Selling, General, & Admin. Expense(SGA) was $8,343 Mil.
Total Current Liabilities was $48,006 Mil.
Long-Term Debt & Capital Lease Obligation was $6,862 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23066 / 301506) / (20537 / 273903)
=0.076503 / 0.074979
=1.0203

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(12610 / 273903) / (12309 / 301506)
=0.046038 / 0.040825
=1.1277

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (47640 + 3880) / 66512) / (1 - (44657 + 3793) / 62690)
=0.225403 / 0.227149
=0.9923

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=301506 / 273903
=1.1008

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(609 / (609 + 3793)) / (636 / (636 + 3880))
=0.138346 / 0.140833
=0.9823

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8432 / 301506) / (8343 / 273903)
=0.027966 / 0.03046
=0.9181

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7046 + 51661) / 66512) / ((6862 + 48006) / 62690)
=0.882653 / 0.875227
=1.0085

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2998 - -182 - 3492) / 66512
=-0.004691

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

McKesson has a M-score of -2.32 suggests that the company is unlikely to be a manipulator.


McKesson Beneish M-Score Related Terms

Thank you for viewing the detailed overview of McKesson's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson (McKesson) Business Description

Traded in Other Exchanges
Address
6555 State Highway 161, Irving, TX, USA, 75039
McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Executives
Brian S. Tyler officer: Chief Executive Officer MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Leann B Smith officer: EVP & Chief HR Officer 6555 NORTH STATE HWY 161, IRVING TX 75039
Thomas L Rodgers officer: EVP, Chief Strategy & BDO 6555 NORTH STATE HWY 161, IRVING TX 75039
Lori A. Schechter officer: EVP, Chief Legal Officer & GC MCKESSON CORPORATION, 6555 NORTH STATE HWY 161, IRVING TX 75039
Nancy Flores officer: EVP, CIO & CTO 6555 NORTH STATE HWY 161, IRVING TX 75039
Britt J. Vitalone officer: EVP & CFO MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Tracy Faber officer: EVP & Chief HR Officer 6555 NORTH STATE HWY 161, IRVING TX 75039
Maria Martinez director THE LANDMARK @ 1 MARKET STREET, SUITE 300, SAN FRANCISCO CA 94105
Susan Nowakowski director 14778 EL RODEO CT., RANCHO SANTA FE CA 92067
Dominic J Caruso director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Donald R Knauss director P O BOX 1734, ATLANTA GA 30301
Bradley E Lerman director MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Webster Roy Dunbar director 5757 N. GREEN BAY AVENUE, MILWAUKEE WI 53209
Rutledge Napoleon B Jr officer: SVP, Controller & CAO 2999 WILDWOOD PARKWAY, ATLANTA GA 30339
Kathleen Wilson-thompson director PO BOX 3599, BATTLE CREEK MI 49016-3599

McKesson (McKesson) Headlines

From GuruFocus

Q2 2024 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2021 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Mckesson Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024